...
机译:CMV血清可参考供体:对CMV感染的临床严重程度和CMV特异性免疫力的影响
Department of Hematology Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Department of Medical Statistics and Bioinformatics Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Department of Hematology Leiden University Medical Center;
Stem cell transplantation; Allogeneic transplantation; Alemtuzumab; Cytomegalovirus infections; T-lymphocytes; Flow cytometry; Cell separation; Chimerism;
机译:CMV血清可参考供体:对CMV感染的临床严重程度和CMV特异性免疫力的影响
机译:降低强度的同种异体干细胞移植用Alemtuzumab的强度降低后,巨细胞病毒(CMV)感染和CMV特异性细胞免疫重建。
机译:CMV特异性T细胞监测提供了CMV-血清阳性供体的CMV-SERONEGATIVE肾移植受体的卓越风险分层
机译:无五相FTFSCW-IPM的无CMV的OW-SVPWM控制的定子绕组匝间短路故障严重性检测
机译:HSV和CMV感染中的细胞免疫反应。
机译:移植:供体CMV状态对CMV阳性移植受者中病毒感染和多功能CMV特异性T细胞重构的影响
机译:第282章
机译:用于治疗人巨细胞病毒(CmV)感染的抗病毒药物的开发,特别是在艾滋病(获得性免疫缺陷)和其他免疫抑制患者中